Zonisamide is a 1,2-benzoxazole derivative featuring a sulfamoylmethyl substituent at the 3-position. It functions as a T-type calcium channel blocker, an antioxidant, and a central nervous system agent, and it is primarily recognized as an anticonvulsant used in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Zonisamide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Amlexanox
pharmaceutical raw material
(−)-hyoscyamine sulfate dihydrate
pharmaceutical raw material
7-Methoxy-1-naphthaleneacetic acid
pharmaceutical raw material
Sulbactam
pharmaceutical raw material
3-Bromomethyl-1,2-benzisoxazole
pharmaceutical intermediate
2-(1,2-benzoxazol-3-yl)ethanoic acid
pharmaceutical intermediate
6-Amino-1,2-benzisoxazole
research compound
3-Amino-6-methoxy-1,2-benzisoxazole
research compound
The international HS code for Zonisamide (CAS 68291-97-4) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1,2-benzoxazol-3-ylmethanesulfonamide
UBQNRHZMVUUOMG-UHFFFAOYSA-N
C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N
Sourcing Zonisamide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.